The NHS and pharma: Let’s work together
August 13, 2007Research and Development, Sales and Marketing NHS, healthcare, industry relations, joint working, pharma
In the last 10 years, pharma’s relationship with the NHS has undergone a transformation. For one thing, it’s difficult now …
NICE claims victory in Alzheimer’s court case
August 10, 2007Sales and Marketing Alzheimer's
NICE will have to issue new guidance on Alzheimer's drugs, but claims the ruling in the judicial review vindicates its …
NICE to re-think blindness drugs decision
August 9, 2007Sales and Marketing AMD, Lucentis, Macugen, NICE
NICE will delay issuing final guidance on two blindness drugs after an unprecedented patient outcry over its decision to block …
FDA approves Pfizer’s first-in-class HIV drug
August 8, 2007Sales and Marketing HIV
Pfizer has won US approval for Selzentry, making it the first new class of oral HIV medicines to reach the …
Indian court dismisses Novartis patent claim
August 8, 2007Sales and Marketing India, Novartis
Novartis has failed in its challenge to India's intellectual property laws as part of its attempt to secure a patent …
Bayer buoyed by Schering integration
August 8, 2007Sales and Marketing
Bayer more than doubled its second quarter pharma sales, which rose to €2.6 billion on the back of the group's …
First national dementia strategy planned
August 7, 2007Plans have been unveiled for the first-ever national dementia strategy as the scale of the problem becomes clear.The number of …
Close encounters with the NHS
August 6, 2007Research and Development, Sales and Marketing NHS, healthcare, industry relations, pharma
Most marketers in the pharma industry understand the need to get alongside and talk to key people in the NHS …
News roundup from Datamonitor
August 3, 2007Sales and Marketing
Astion's lupus drug to receive orphan statusEuropean health authorities have recommended that Copenhagen-based Astion Pharma's cutaneous lupus erythematosus candidate be …
FDA allows Avandia to stay but damage already done
August 3, 2007Sales and Marketing diabetes
An FDA advisory committee has recommended that GlaxoSmithKline's diabetes treatment Avandia should remain available on the US market, albeit with …
Germany loses out in Astellas restructuring
August 2, 2007Sales and Marketing Astellas, Germany
Astellas has announced streamlining and cutbacks to its operations across Europe, with operations in Germany losing staff in its saleforce …
Tough talking ahead as government signals end to UK medicines pricing deal
August 2, 2007ABPI, par
The government has told the UK pharmaceutical industry it wants to talk about the future of medicines pricing in the …
ReNeuron acquires Californian base and new diabetes technology
August 2, 2007Research and Development
Pioneering British stem cell research company ReNeuron has bought the Californian company, AmCyte – a move it hopes will make …
Prevenar success boosts UK manufacturing
July 30, 2007Manufacturing and Production
Wyeth has increased the capacity at its manufacturing site in Havant, Hampshire in response to growing demand for its vaccine …
Continuous dose contraceptive launched in US
July 30, 2007Sales and Marketing contraception
Wyeth's Lybrel, the first ever contraceptive pill designed to be taken by women 365 days a year, has been launched …
Are you connecting with your customers?
July 30, 2007Sales and Marketing customers, marketing
Insights (or customer insights) seems to be the current buzzword in the pharmaceutical industry. But is it something we should …
Latest news from Datamonitor
July 27, 2007Research and Development, Sales and Marketing
BioMS's multiple sclerosis trial gets positive reviewBioMS Medical's relapsing-remitting multiple sclerosis trial has received a positive review from the data …
AstraZeneca to make further job cuts
July 26, 2007Sales and Marketing
Thousands of employees in sales, marketing, R&D and back office staff will lose their jobs at AstraZeneca as the pharma …
Animal rights attacks fall to new low
July 26, 2007Sales and Marketing
Attacks by animal rights extremists in the UK have dropped to a new low – but the pharmaceutical industry says …
Avandia safety scare costs GSK $200m
July 26, 2007Sales and Marketing GSK
GlaxoSmithKline saw its performance in the second quarter of this year badly affected by a 22% slump in sales of …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
